Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use of pegfilgrastim in severe chronic neutropenia
2005-003096-20Phase 2Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pegfilgrastim in severe chronic neutropenia (SCN), sponsored by Istituto Giannina Gaslini. Started Jul 2005; status: active.
02
Drugs
pegfilgrastim
03
Conditions
severe chronic neutropenia (SCN)
Beyond the preview
Go deeper on 2005-003096-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003096-20.